Acmopatide

Acmopatide (Compound E-153) is a dual-acting GIP/GLP-1 receptor agonist. Acmopatide is used in anti-diabetic research[1].

2377239-31-9

12352209

GLP Receptor

GPCR/G Protein

Metabolic Disease

O=C(NCC(NC(C(O)C)C(NC(CC1=CC=CC=C1)C(NC(C(O)C)C(NC(CO)C(NC(CC(O)=O)C(NC(CC2=CC=C(C=C2)O)C(NC(CO)C(NC(C(C)CC)C(NC(CC3=CC=C(C=C3)O)C(NC(CC(C)C)C(NC(CC(O)=O)C(NC(CCCCN)C(NC(CCC(N)=O)C(NC(C)C(NC(C)C(NC(C)(C)C(NC(CCC(O)=O)C(NC(CC4=CC=CC=C4)C(NC(C(C)C)C(NC(CC(N)=O)C(NC(CC5=CNC6=CC=CC=C56)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(C)C(NCC(NCC(N7C(CCC7)C(NC(CO)C(NC(CO)C(NCC(NC(C)C(N8C(CCC8)C(N9C(CCC9)C(N%10[C@@H](CCC%10)C(NC(CO)C(NC(CCCCNC(CC[C@H](NC(CCCCCCCCCCCCCCC)=O)C(O)=O)=O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(CCC(O)=O)NC(CSCC(NCCN%11C(CCCC%11)=O)=O)=O

C214H323N47O64S

4610.20

[1]Johan ENQUIST, et al. Modulators of g-protein coupled receptors. WO2019183577A1. Carmot Therapeutics, Inc. 2019-03-22.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P11233/

Peptides

No Development Reported